Yellow Fever Vaccination of Human Immunodeficiency Virus-Infected Patients: Report of 2 Cases

M. C. Receveur, Rodolphe Thiébaut, S. Védy, Denis Malvy, P. Mercié, M. Le BrasClinical 2000 · DOI

Abstract

Yellow fever vaccine (17D, a live attenuated virus vaccine) was effective and safe in 2 human immunodeficiency virus-infected patients without severe immunosuppression, one of whom traveled to Kenya and the other of whom traveled to Senegal.
BibTeX
@inproceedings{receveur2000yellow,
  author = {M. C. Receveur and Rodolphe Thiébaut and S. Védy and Denis Malvy and P. Mercié and M. Le Bras},
  title = {{Yellow Fever Vaccination of Human Immunodeficiency Virus-Infected Patients: Report of 2 Cases}},
  booktitle = {Clinical},
  year = {2000},
  doi = {10.1086/314031},
}

Loading related content...

Figure